{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:10:02Z","timestamp":1748401802635,"version":"3.41.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12185-015-1816-y","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T14:14:47Z","timestamp":1432563287000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology"],"prefix":"10.1007","volume":"102","author":[{"given":"Ozlen","family":"Bektas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Uner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seda Muruvvet","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eylem","family":"Eliacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Uz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Celalettin","family":"Haznedaro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Goker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilgun","family":"Sayinalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hal\u00fbk","family":"Demiroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman Ilhami","family":"Ozcebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya","family":"Buyukasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"1816_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","volume":"11","author":"L Sokol","year":"2006","unstructured":"Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist. 2006;11:263\u201373.","journal-title":"Oncologist"},{"key":"1816_CR2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semarthrit.2013.07.002","volume":"43","author":"A Audemard","year":"2013","unstructured":"Audemard A, Lamy T, Bareau B, Sicre F, Suarez F, Truquet F, et al. Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases. Semin Arthritis Rheum. 2013;43:362\u20136.","journal-title":"Semin Arthritis Rheum"},{"key":"1816_CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11899-007-0038-7","volume":"2","author":"L Sokol","year":"2007","unstructured":"Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Curr Hematol Malig Rep. 2007;2:278\u201382.","journal-title":"Curr Hematol Malig Rep"},{"doi-asserted-by":"crossref","unstructured":"Schiller GJ. Current clinical oncology: chronic leukemias and lymphomas: biology, pathophysiology, and clinical management. In: Benekli M, Baer MR, editors. Large granular lymphocyte proliferative disease. 2003;153\u201383.","key":"1816_CR4","DOI":"10.1007\/978-1-59259-308-8_7"},{"doi-asserted-by":"crossref","unstructured":"Loughran TP, Xiaopan Y, John MB, Mark RL, Andrew ME, Martin ST. Results of a prospective multicenter phase II study of initial treatment with methotrexate in LGL leukemia (ECOG Protocol E5998). 2010.","key":"1816_CR5","DOI":"10.1182\/blood.V116.21.702.702"},{"key":"1816_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.blre.2014.02.001","volume":"28","author":"SN Steinway","year":"2014","unstructured":"Steinway SN, LeBlanc F, Loughran TP Jr. The pathogenesis and treatment of large granular lymphocyte leukemia. Blood Rev. 2014;28:87\u201394.","journal-title":"Blood Rev"},{"key":"1816_CR7","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/annonc\/mdq233","volume":"21","author":"T Schroeder","year":"2010","unstructured":"Schroeder T, Ruf L, Bernhardt A, Hildebrandt B, Aivado M, Aul C, et al. Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients. Ann Oncol. 2010;21:2267\u201371.","journal-title":"Ann Oncol"},{"key":"1816_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2141.2010.08494.x","volume":"152","author":"C Dearden","year":"2011","unstructured":"Dearden C. Large granular lymphocytic leukaemia pathogenesis and management. Br J Haematol. 2011;152:273\u201383.","journal-title":"Br J Haematol"},{"key":"1816_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2006.06374.x","volume":"136","author":"I Sabnani","year":"2007","unstructured":"Sabnani I, Tsang P. Are clonal T-cell large granular lymphocytes to blame for unexplained haematological abnormalities? Br J Haematol. 2007;136:30\u20137.","journal-title":"Br J Haematol"},{"doi-asserted-by":"crossref","unstructured":"Lamy T, Loughran TP Jr. How I treat LGL leukemia. Blood. 2011;117:2764\u201374.","key":"1816_CR10","DOI":"10.1182\/blood-2010-07-296962"},{"key":"1816_CR11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/asheducation.V2012.1.652.3798658","volume":"2012","author":"D Zhang","year":"2012","unstructured":"Zhang D, Loughran TP Jr. Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematol Am Soc Hematol Educ Program. 2012;2012:652\u20139.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1816_CR12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1309\/A8FHDA0VVRJ05GJP","volume":"127","author":"DP O\u2019Malley","year":"2007","unstructured":"O\u2019Malley DP. T-cell large granular leukemia and related proliferations. Am J Clin Pathol. 2007;127:850\u20139.","journal-title":"Am J Clin Pathol"},{"doi-asserted-by":"crossref","unstructured":"Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;89:256\u201360.","key":"1816_CR13","DOI":"10.1182\/blood.V89.1.256"},{"key":"1816_CR14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)63032-5","volume":"159","author":"M Lima","year":"2001","unstructured":"Lima M, Almeida J, Santos AH, Dos Anjos TM, Alguero MC, Queiros ML, et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)\/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol. 2001;159:1861\u20138.","journal-title":"Am J Pathol"},{"doi-asserted-by":"crossref","unstructured":"Posnett DN, Sinha R, Kabak S, Russo C: Clonal populations of T cells in normal elderly humans: the T cell equivalent to \u201cbenign monoclonal gammapathy\u201d. J Exp Med. 1994;179:609\u201318.","key":"1816_CR15","DOI":"10.1084\/jem.179.2.609"},{"key":"1816_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/intimm\/10.9.1281","volume":"10","author":"A Wack","year":"1998","unstructured":"Wack A, Cossarizza A, Heltai S, Barbieri D, D\u2019Addato S, Fransceschi C, et al. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol. 1998;10:1281\u20138.","journal-title":"Int Immunol"},{"doi-asserted-by":"crossref","unstructured":"Morice WG, Kurtin PJ, Tefferi A, Hanson CA. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood. 2002;99:268\u201374.","key":"1816_CR17","DOI":"10.1182\/blood.V99.1.268"},{"key":"1816_CR18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/10428191003706947","volume":"51","author":"AF Fortune","year":"2010","unstructured":"Fortune AF, Kelly K, Sargent J, O\u2019Brien D, Quinn F, Chadwick N, et al. Large granular lymphocyte leukemia: natural history and response to treatment. Leuk Lymphoma. 2010;51:839\u201345.","journal-title":"Leuk Lymphoma"},{"doi-asserted-by":"crossref","unstructured":"Shah A, Diehl LF, St Clair EW. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia. Clin Immunol. 2009;132:145\u201352.","key":"1816_CR19","DOI":"10.1016\/j.clim.2009.03.515"},{"doi-asserted-by":"crossref","unstructured":"Go RS, Li CY, Tefferi A, Phyliky RL. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood. 2001;98:483\u201385.","key":"1816_CR20","DOI":"10.1182\/blood.V98.2.483"},{"key":"1816_CR21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2141.1999.01734.x","volume":"107","author":"K Akashi","year":"1999","unstructured":"Akashi K, Shibuya T, Taniguchi S, Hayashi S, Iwasaki H, Teshima T, et al. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes. Br J Haematol. 1999;107:670\u20133.","journal-title":"Br J Haematol"},{"key":"1816_CR22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hoc.2013.03.001","volume":"27","author":"G Kistangari","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27:495\u2013520.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1816_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.20375","volume":"79","author":"PF Fogarty","year":"2005","unstructured":"Fogarty PF, Stetler-Stevenson M, Pereira A, Dunbar CE. Large granular lymphocytic proliferation-associated cyclic thrombocytopenia. Am J Hematol. 2005;79:334\u20136.","journal-title":"Am J Hematol"},{"key":"1816_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.leukres.2007.08.012","volume":"32","author":"DW Lai","year":"2008","unstructured":"Lai DW, Loughran TP Jr, Maciejewski JP, Sasu S, Song SX, Epling-Burnette PK, et al. Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia. Leuk Res. 2008;32:823\u20137.","journal-title":"Leuk Res"},{"key":"1816_CR25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.10024","volume":"69","author":"D Ergas","year":"2002","unstructured":"Ergas D, Tsimanis A, Shtalrid M, Duskin C, Berrebi A. T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjogren\u2019s syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia. Am J Hematol. 2002;69:132\u20134.","journal-title":"Am J Hematol"},{"doi-asserted-by":"crossref","unstructured":"Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood. 1994;84:1620\u201327.","key":"1816_CR26","DOI":"10.1182\/blood.V84.5.1620.bloodjournal8451620"},{"key":"1816_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/asheducation.V2012.1.485.3798522","volume":"2012","author":"P Valent","year":"2012","unstructured":"Valent P. Low blood counts: immune mediated, idiopathic, or myelodysplasia. Hematology Am Soc Hematol Educ Program. 2012;2012:485\u201391.","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-015-1816-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1816-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:52:50Z","timestamp":1748400770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-015-1816-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1007\/s12185-015-1816-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}